Debt to EBITDA ratio Analysis of Adc Therapeutics SA - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of ADCT
Sep-23-0.882Very Poor Debt to EBITDA | Sep-22-0.941Very Poor Debt to EBITDA | Growth6.29% |
Debt to EBITDA Analysis of Adc Therapeutics SA
| Debt to EBITDA Ratio of ADCT has grown by 6.29 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of -0.0099 was highest in Year Sep-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.941 was lowest in Year Sep-22 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.882 is lower than Average Debt to EBITDA of -0.576 in last five years. |
Other Debt to EBITDA Related Info of ADCT that may interest you.
Adc Therapeutics SA Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ADCT | 3.43 | 3.44 | 0.291 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Poor Stability Stock | |
FY - Historical Debt to EBITDA of Adc Therapeutics SA
| Period | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.882 | -0.941 | -0.576 | -0.471 | -0.0099 | 0 | 0 |
| Change | 6.29 % | -63.50 % | -22.09 % | -4652.43 % |
FY Chart of Debt to EBITDA of Adc Therapeutics SA
Note : All Data Generated at the End of Trading Hours (EOD Data)